StockData
Gain Therapeutics, Inc. logo

Gain Therapeutics, Inc. (GANX) KPIs and segments

GANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/30
$1.18+0.24 (+25.51%)

Close on Nov 17, 2026Market cap $51.50MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Gain Therapeutics's business

Coming soon

This tab will track the numbers specific to Gain Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?